Evotec offers to acquire cyprotex
WebOct 27, 2016 · German drug discovery company Evotec announced Wednesday that it agreed to acquire contract research organization Cyprotex for €62 million ($67.7 million). The deal is the latest in a string of recent acquisitions for Evotec. The company bought another CRO, Euprotec Ltd., in May 2014 for $2.3 million upfront. WebAbout us. Founded in 1999, Cyprotex (www.cyprotex.com) has grown to become an industry leader in in vitro and in silico ADME-Tox. The company, with sites in the UK and …
Evotec offers to acquire cyprotex
Did you know?
WebYou have not yet registered? Get your account for free. Register Here WebOct 27, 2016 · Evotec AG announced that it has made an offer to acquire Cyprotex PLC, a specialist pre-clinical contract research organisation in ADME-Tox and DMPK. …
WebFeb 15, 2024 · Further, Cyprotex’ customers and partners will stand to benefit from additional specialist services e.g. a full suite of transporter assays and a high-throughput transcriptomics offering for predicting drug-induced toxicity, which Cyprotex performs together with its parent company Evotec. With 30,000 square feet, Cyprotex’ new … WebOct 26, 2016 · * Evotec AG announces its intent to acquire Cyprotex plc * Offer is intended to be implemented by a scheme of arrangement regulated by uk takeover code, …
WebNov 4, 2024 · Evotec SE today announced the signing of a definitive agreement under which Evotec will acquire 100% of the capital of Rigenerand Srl, a leading cell technology company, for a purchase price of € 23 m. ... Evotec AG today announced that it has made an offer to acquire Cyprotex PLC ("Cyprotex", AIM: CRX-GB), a specialist pre-clinical … WebApr 29, 2024 · The Story of Cyprotex – 20 Years of Excellence. Posted 29th April 2024 by Cyprotex. It’s been quite a journey over the past 20 years! In this blog, we travel down memory lane as we track how Cyprotex has grown to become one of world’s most well recognised and trusted ADME-Tox providers. The story begins in April 1999 when …
WebCyprotex’s customers will now be able to access Evotec’s integrated and standalone drug discovery services and the acquisition expands Cyprotex’s service portfolio to include medicinal chemistry, structural biology and in vitro and in vivo pharmacology services. Evotec can also offer specialist expertise in key therapeutic areas such as ...
WebOct 26, 2016 · Evotec said today it has offered to acquire Cyprotex for £55.36 million ($67.6 million) in a deal designed to strengthen the buyer’s drug discovery efforts. … sdm fairlawn plazaWebDec 15, 2016 · Acquisition of 100% shares in Cyprotex PLC effective 14 December 2016; Evotec is paying £ 55.7 m in cash for the full share capital of Cyprotex and funding of … peace love buckeyes pngWebOct 26, 2016 · Evotec made an offer to acquire all 26.1 million shares of Cyprotex for about £55.36 million in cash. peace love basketball hoodie slamWeb22 rows · Oct 26, 2016 · Evotec will pay approximately £ 55.36 m (EUR 62.00 m; £/EUR exchange rate of 1.12) in cash for the ... sdm gift card balanceWebOct 26, 2016 · Evotec AG today announced that it has made an offer to acquire Cyprotex PLC , a specialist... January 20, 2024 sdm food martWebOct 26, 2016 · Data & APIs. Events. Marketfy sdm headon roadWebOct 26, 2016 · The offer of 1.60 £ per Cyprotex share reflects a 9.4% premium to the VWAP of the past 30 trading days at AIM. The offer is intended to be implemented by a scheme of arrangement regulated by the UK takeover code, with already >50% shares secured irrevocable. The acquisition will add to Evotec’s revenues and be accretive to … sd memory card usb reader